Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMX1 pseudogene 2 (TMX1P2) is a noncoding genomic sequence that bears similarity to the functional TMX1 gene but contains disabling mutations that prevent it from encoding a functional protein. Pseudogenes like TMX1P2 may be transcriptionally inactive or may generate noncoding RNA; while some pseudogenes are known to regulate their parental genes via RNA-mediated mechanisms, there is currently no evidence that TMX1P2 has any such regulatory or disease-related role[4][5][11]. It is not a known or potential therapeutic target. Key points: - TMX1P2 is a pseudogene, not a receptor, enzyme, or any other characterized therapeutic target. - There is no evidence of biological function, disease involvement, or drug interaction specifically associated with TMX1P2. - If a functional TMX1-related target is of interest, the correct entry would be "Thioredoxin-related transmembrane protein 1 (TMX1)". If the search intended to find information for TMX1 (the protein-coding gene), significant re-interpretation and different structured data would be required.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMX1 pseudogene 2 (TMX1P2).